home / stock / alpn / alpn news

ALPN News and Press, Alpine Immune Sciences Inc. From 02/27/19

Stock Information
Company Name: Alpine Immune Sciences Inc.
Stock Symbol: ALPN
Market: NASDAQ
Website: alpineimmunesciences.com
Menu
ALPN ALPN Quote ALPN Short ALPN News ALPN Articles ALPN Message Board
Get ALPN Alerts

News, Short Squeeze, Breakout and More Instantly...
ALPN - Alpine Immune Sciences to Present at Two Upcoming Investor Conferences

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and other diseases, today announced the company will participate in two upcoming investor conferences in March. Cow...
ALPN - Alpine Immune Sciences Presents Preclinical ALPN-101 GvHD Data at the 2019 Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR (TCT Meetings)

Appoints Immunology Veteran Vijay Kuchroo, DVM, PhD to Scientific Advisory Board Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and other diseases, today anno...

ALPN - Alpine Immune Sciences Announces First Subjects Dosed in Phase I Clinical Trial for Lead Autoimmune/Inflammatory Disease Program ALPN-101

First Dual ICOS/CD28 Inhibitor to Enter Clinical Trials Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and other diseases, today announced successful initiati...

Previous 10 Next 10